The atherogenic lipoprotein receptor pathway and omega-3 acids as risk modulators of type 2 diabetes in humans

GRADUATE STUDENT OFFER - DOCTORATE DEGREE

Project Title : The atherogenic lipoprotein receptor pathway and omega-3 acids as risk modulators of type 2 diabetes in humans
Professor responsible : May Faraj
Start Date : As soon as possible

Project Description
This project is a 5-year clinical trial that is underway at IRCM. The objective is to examine the risk factors for type 2 diabetes before and after the use of omega-3 acids for 6 months in 48 overweight and obese subjects. We will study adipose tissue physiology, insulin secretion and sensitivity, lipid metabolism and inflammation (NLRP3 inflammasome) with in vivo and ex vivo techniques. The project will also examine the metabolic and inflammatory pathways regulated by atherogenic lipoproteins and omega-3 acids in human immune cells.        
Students will receive a $23,000 per year doctoral award.

Research areas
Type 2 diabetes, cardiovascular disease, obesity, lipid and glucose metabolism, innate immunity, nutrition

Research environment
Clinical Research Institute of Montreal (IRCM)

Profile sought
Responsibility, self-reliance, punctuality, independence, willingness to learn and excel, teamwork and collaboration skills, positivity, and professionalism. Experience in basic and/or clinical research in the field of cardiometabolic diseases is an advantage.

Requirements and Conditions
MSc in Health Sciences with academic excellence (GPA > 3.6), bilingual (English and French), Canadian citizenship (to apply for CIHR, FRQ santé…)

Required documents
CV, transcripts and cover letter.

Please email your documents to
May.faraj@ircm.qc.ca

Retour aux opportunités

Submit your candidacy

Newsletter

Discoveries,
events and more

Subscribe

IRCM Foundation

Be part of the
solution

Support health research